Regulation of ionotropic glutamate receptor subunits in different rat brain areas by a preferential sigma1 receptor ligand and potential atypical antipsychotic

Neuropsychopharmacology

Volumn 23, Issue 5, 2000, Pages 539-546

  Guitart, Xavier ^a   Méndez, Raúl ^a   Ovalle, Sergio ^a   Andreu, Francesc ^a   Carceller, Alicia ^a   Farré, Antoni J ^a   Zamanillo, Daniel ^a  

^a Laboratorios Dr Esteve SA   (Spain)

Author keywords

AMPA receptor; Antipsychotic; NMDA receptor; Protein regulation; Schizophrenia; Sigma receptor

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; QUISQUALIC ACID RECEPTOR; RECEPTOR SUBUNIT; SIGMA OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SCHIZOPHRENIA;

ANIMAL; ANTIPSYCHOTIC AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN CHEMISTRY; LIGANDS; MALE; NERVE TISSUE PROTEINS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; RNA PROBES; RNA, MESSENGER; TRIAZOLES;

EID: 0343278973     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00142-1     Document Type: Article

References (40)

1. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E. Jr., Jones E.G. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci. 16:1996;19-30.
2. Anden N.-E., Butcher S.G., Corrodi H., Fuxe K., Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol. 11:1970;303-314.
3. Angrist B., Sathananthan G., Wilk S., Gershon S. Amphetamine psychosis. behavioral and biochemical aspects J Psychiatr Res. 11:1974;13-23.
4. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinsons's disease. Trends Neurosci. 13:1990;272-276.
5. Creese I., Burt D.R., Snyder S.H. Dopamine receptor binding predicts clinical pharmacological potencies of antipsychotic drugs. Science. 192:1976;481-483.
6. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia. a review and reconceptualization Am J Psychiatry. 148:1991;1474-1486.
7. Deutsch S.I., Mastropaolo J., Scwartz B.L., Rosse R.B., Morihisa J.M. A "glutamatergic" hypothesis of schizophrenia. Rationale for pharmacotherapy with glycine. Clin Neuropharmacol. 12:1989;1-13.
8. Durand G.M., Zukin R.S. Developmental regulation of mRNAs encoding rat brain kainate/AMPA receptors. a northern analysis study J Neurochem. 61:1993;2239-2246.
9. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine, dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev. 20:1995;250-267.
10. Fitzgerald L.W., Deutch A.Y., Gasic G., Heinemann S.F., Nestler E.J. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci. 15:1995;2453-2461.
11. Gandolfi O., Dall'Olio R. Modulatory role of dopamine on excitatory amino acid receptors. Prog Neuropsychopharmacol Biol Psychiatry. 20:1996;659-671.
12. Grimwood S., Slater P., Deakin J.F.W., Hutson P.H. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport. 10:1999;461-465.
13. Guitart X., Farré A.J. The effect of E-5842, a σ receptor ligand and potential atypical antipsychotic, on Fos expression in rat forebrain. Eur J Pharmacol. 363:1998;127-130.
14. Guitart X., Codony X., Ballarín M., Dordal A., Farré A.J. E-5842. a new potent and preferential sigma ligand. Preclinical pharmacological profile CNS Drug Rev. 4:1998;201-224.
15. Healy D.J., Meador-Woodruff J.H. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum. Mol Brain Res. 47:1997;331-338.
16. Healy D.J., Haroutunian V., Powchik P., Davidson M., Davis K.L., Watson S.J., Meador-Woodruff J.H. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology. 19:1998;278-286.
17. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 17:1994;31-108.
18. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 148:1991;1301-1308.
19. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M., Mishna M. Molecular diversity of the NMDA receptor channel. Nature. 358:1992;36-41.
20. Laurie D.J., Seeburg P.H. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur J Pharmacol. 268:1994;335-345.
21. Lowry O.H., Rosenburg N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
22. McCoy L., Cox C., Richfield E.K. Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain. Eur J Pharmacol. 318:1996;41-45.
23. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., Mishina M. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature. 357:1992;70-74.
24. Meltzer H.Y., Stahl S.M. The dopamine hypothesis of schizophrenia. a review Schizophrenia Bull. 2:1976;19-76.
25. Moghaddam B. Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog Neuro-Psychopharmacol & Biol Psychiatry. 18:1994;859-870.
26. Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D., Yamaguchi S., Kawabata S., Okada M. Glutamate receptors. brain function and signal transduction Brain Res Brain Res Rev. 26:1998;529-542.
27. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 52:1995;998-1007.
28. Ossowka K., Pietraszek M., Wardas J., Nowak G., Wolfarth S. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats. Psychopharmacology. 359:1999;280-287.
29. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed:1986;Academic Press, London.
30. Porter R.H.P., Eastwood S.L., Harrison P.J. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res. 751:1997;217-231.
31. 1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons. Eur J Pharmacol. 378:1999;31-37.
32. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1987;133-152.
33. Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:1976;717-719.
34. Simpson M.D.C., Slater P., Royston M.C., Deakin J.F.W. Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effect of disease process and neuroleptic medication. Schizophr Res. 6:1992;41-48.
35. Tamminga C.A. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol. 12:1995;21-36.
36. Tang Y.-P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., Liu G., Tsien J.Z. Genetic enhancement of learning and memory in mice. Nature. 401:1999;63-69.
37. Tarazi F.I., Florijn W.J., Creese I. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology. 128:1996;371-379.
38. Tascedda F., Lovati E., Blom J.M.C., Muzzioli P., Brunello N., Racagni G., Riva M.A. Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). Neuropsychopharmacology. 21:1999;211-217.
39. Weinberger D.R., Berman K.F., Illowsky B.P. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia III. a new cohort and evidence for a monoaminergic mechanism Arch Gen Psychiatry. 45:1988;609-615.
40. Zamanillo D., Sprengel R., Hvalby O., Jensen V., Burnashev N., Rozov A., Kaiser K.M.M., Köster H.J., Borchardt T., Worley P., Lübke J., Frotscher M., Kelly P.H., Sommer B., Andersen P., Seeburg P.H., Sakmann B. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science. 284:1999;1805-1811.